The fact that silencing of RUNX3 gene at the transcriptional level and functional inactivation at the protein level in esophagus cancer are strongly correlated with poor prognosis and may occur in early phase of tumor initiation, making it a promising target for therapeutic approaches. Here, RUNX3 is linked to neoplasm.